Cefsulodin (formerly SCE-129) is a cephalosporin which has in vitro activity against Pseudomonas aeruginosa, Staphylococcus aureus, and most other gram-positive cocci (4, 7-9). However, it has very little activity against the enterococci and members of the Enterobacteriaceae (7-9). Such a limited-spectrum antimicrobial agent may be advantageous when treating bacterial infections of known etiology.
Cefsulodin (formerly SCE-129) is a cephalosporin which has in vitro activity against Pseudomonas aeruginosa, Staphylococcus aureus, and most other gram-positive cocci (4, (7) (8) (9) . However, it has very little activity against the enterococci and members of the Enterobacteriaceae (7) (8) (9) . Such a limited-spectrum antimicrobial agent may be advantageous when treating bacterial infections of known etiology.
In the present report we compare cefsulodin with four penicillins with antipseudomonal activity (carbenicillin, ticarcillin, mezlocillin, and piperacillin). For this purpose, 778 The series of P. aeruginosa isolates included 62 strains that were resistant to gentamicin (MIC >8 jig/ml) and 28 strains that were also resistant to amikacin (MIC >16 .tg/ml). Eight gentamicin-resistant strains and six amikacinresistant strains were also resistant to cefsulodin. Six strains were very resistant to cefsulodin (MIC -512 Ag/ml); five of those six strains were also fully resistant to both amikacin and gentamicin.
The in vitro data obtained with 86 S. aureus strains are also summarized in Table 1 . Cefsulodin appears to be resistant to staphylococcal penicillinase since the MICs for penicillin-susceptible and penicillin-resistant strains were essentially the same. The penicillins were more active against susceptible strains but were not active against penicillin-resistant S. aureus (2, 3) . Similar results were observed with the 14 strains of S. epidermidis (data not shown). (Table 4) . The data were then pooled, and geometric mean MICs were correlated with arithmetic mean zone diameters (Fig.  1) . The regression formulae calculated from data provided by the three individual laboratories were similar but not identical. When the data were pooled, the regression formulae appeared to represent a very satisfactory assessment of the relationship between zone sizes and MIC values (Fig. 1) The present report describes a unique attempt to correlate zone sizes to MIC values since all strains were tested in three separate laboratories. Consequently, the data could be pooled, and geometric mean MICs could be plotted against arithmetic mean zone diameters. Regression formulae calculated from data obtained in the three laboratories differed somewhat because of minor technical differences. It was felt that the pooled data represented the most appropriate estimate of the correlations between MICs and zone diameters (Fig. 1) (1) .
If MIC breakpoints of -64 Mg/ml for resistant and '16 yg/ml for susceptible strains are found to be clinically relevant, zone size breakpoints should be resistant '14 mm and susceptible '18 mm. Alternatively, MIC breakpoints of resistant -32 ,ug/ml and susceptible c8 yg/ml may prove to be more appropriate, if reduced dosages are to be commonly utilized. In that case, zone-size breakpoints of susceptible .21 mm and resistant <17 mm would be appropriate for tests with 30-tig cefsulodin disks. Such a drop in MIC breakpoints would affect the interpretive category of only 7/% of our P. aeruginosa isolates. With either of the MIC breakpoints, the disk test is quite satisfactory. No major or verv major interpretive discrepancies and less than 1% minor discrepancies between MIC and disk test categories were recorded when the suggested zonesize standards were applied to our pooled data (Fig. 1) .
In summary, cefsulodin is a potentially useful antimicrobial agent with specific activitv against 
